Development of a cross-serotype Adenovirus vaccine
Award amount
$99,798Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Defense
- Branch
- Not reported
- Recipient company
- BIOLOGICAL MIMETICS, INC.
- Proposal award date
- 2015-09-29
- Contract end date
- 2016-04-28
- UEI
- LJARDLY9MMK5
- Solicitation number
- 2015.1
- Topic code
- A15-051
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Subunit Vaccine Against Acinetobacter Baumannii
- FAST-CRISPR-BASED Diagnostic for Parasites
- An instrument-free malaria diagnostic
- An Improved PCV-2 Vaccine
- Development of a Staph Aureus Vaccine
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Next-Generation Adenovirus Vaccine
- Next-Generation Adenovirus Vaccine
- Next Generation of Multivalent Adenovirus Vaccines Based on Novel Virus-Like Particle (VLP) Technology
- Next-Generation Adenovirus Vaccine
Research funding history
21 SBIR/STTR records share this UEI (2001–2025). Reported award amounts total $15,251,994. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, Department of Agriculture